TOHO HOLDINGS CO., LTD. is pleased to announce that, at Board of Directors meeting held today, it was decided to establish the Governance Enhancement Special Committee as an advisory committee to the Board of Directors as follows.

【Objectives of Governance Enhancement Special Committee】
Under the corporate slogan, “Total commitment to good health,” the Group pursues its mission to contribute to society and healthcare through the stable supply of pharmaceuticals. We will strive to become a corporate group relied upon and continuously supported by all stakeholders including people who wish to be healthy, customers, local communities, shareholders and employees. The Group has placed the highest priority on compliance with relevant laws and regulations and risk management, after TOHO PHARMACEUTICAL CO., LTD. and Kyushu Toho Co., Ltd. received cease and desist orders, etc. for violation of Article 3 of the Antimonopoly Act. We have decided to establish the Governance Enhancement Special Committee (hereinafter referred to as the “Committee”) as an advisory committee to the Board of Directors to further strengthen the Group’s governance, including compliance and risk management. The Committee will consist of members independent of the Company to verify the internal control organization and provide advice and recommendations on governance from an objective and professional standpoint. The Group intends to further strengthen its governance structure based on the advice and recommendations of the Committee.